Nutrient Synergy
FDA Pilot Aims to Accelerate U.S. Drug Trials
The FDA's new pilot program aims to accelerate U.S. drug trials, reducing time from discovery to first-in-human studies.
By emily johnson · Sep 17, 2026
Category: Nutrient Synergy
Nutrient Synergy
AbbVie tests new approach for menstrual migraine treatment
AbbVie’s Qulipta becomes first oral CGRP inhibitor to succeed in phase 3 menstrual migraine trials, offering hope for resistant cases.
By Samoyed · Sep 12, 2026
Nutrient Synergy
Ivonescimab Meets Overall Survival Goal in NSCLC
Ivonescimab surpasses Keytruda in overall survival for NSCLC first-line treatment, demonstrating potential breakthrough in lung cancer therapy.
By emily johnson · Sep 7, 2026
Nutrient Synergy
Alumis lupus drug advances after trial setback
Alumis advances its lupus drug to Phase III trials despite mixed Phase IIb results, targeting a specific patient subgroup for better outcomes.
By Samoyed · Sep 3, 2026
Nutrient Synergy
In-Depth Analysis Pharmacy Landscape in Indonesia
The pharmacy sector in Indonesia plays a crucial role in the nation’s healthcare system. As one of the largest countries in Southeast Asia, Indonesia’s diverse...
By Samoyed · Aug 27, 2026